TY - CHAP A1 - Monika Sharma A2 - Patrick M. Flood ED1 - Raymond Chuen-Chung Chang ED2 - Yuen-Shan Ho Y1 - 2019-08-28 PY - 2019 T1 - Adrenergic Receptors as Pharmacological Targets for Neuroinflammation and Neurodegeneration in Parkinson’s Disease N2 - Neuroprotection is a strategy to prevent or delay the progression of chronic neurodegenerative diseases, acute neurological disorders, or even mental disorders. The major aim of this book is to focus on different approaches to achieve neuroprotection. In this book, there are chapters discussing imidazoline ligands and opioid ligands in Alzheimer's disease, the beneficial effects of adenosine A2A receptor antagonist, adrenergic receptor agonists and antagonists modulating microglial responses, and different approaches to achieve neuroprotection against aging-associated macular degeneration. This book will give insights to scientists in the field to stimulate their research, medical professionals to review their clinical practices, and others who would like to learn more about different neuroprotective approaches. BT - Neuroprotection SP - Ch. 4 UR - https://doi.org/10.5772/intechopen.81343 DO - 10.5772/intechopen.81343 SN - 978-1-78984-737-6 PB - IntechOpen CY - Rijeka Y2 - 2021-01-22 ER -